12:00 AM
 | 
May 03, 1999
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

La Jolla Pharma preclinical data

LJPC said that mice receiving LJP 920 had significantly lower levels of B cells and antibodies associated...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >